Insight into the physiological and pathological roles of the aryl hydrocarbon receptor pathway in glucose homeostasis, insulin resistance, and diabetes development

• Published in: Cellular & molecular biology letters 2022-11, Vol.27 (1), p.103-26, Article 103
• Main Authors: Sayed, Tahseen S, Maayah, Zaid H, Zeidan, Heba A, Agouni, Abdelali, Korashy, Hesham M
• Format: Article
• Language: English
• Subjects: Adipose tissue; Aryl hydrocarbon receptor; Cardiovascular diseases; Comorbidity; Contaminants; Cytochrome P-450 CYP1A1; Cytochrome P450; Diabetes; Diabetes Mellitus; Dioxins; Environmental Pollutants; Environmental toxicants; Epidemiology; Gluconeogenesis; Glucose; Glucose hemostasis; Hemostasis; Homeostasis; Humans; Hydrocarbons; Hypoxia-inducible factors; Insulin; Insulin Resistance; Insulin secretion; Ligands; Liver; Localization; Metabolism; Molecular modelling; Oxidative stress; Pancreas; Pancreatitis; Pathogenesis; PCB; Physiology; Pollutants; Polychlorinated biphenyls; Proteins; Receptors, Aryl Hydrocarbon - genetics; Review; Rheumatoid arthritis; Secretion; Systemic lupus erythematosus; Transcription factors
• ISSN: 1425-8153; 1689-1392
• DOI: 10.1186/s11658-022-00397-7

The aryl hydrocarbon receptor (AhR) is a ligand-activated transcriptional factor that mediates the toxicities of several environmental pollutants. Decades of research have been carried out to understand the role of AhR as a novel mechanism for disease development. Its involvement in the pathogenesis of cancer, cardiovascular diseases, rheumatoid arthritis, and systemic lupus erythematosus have long been known. One of the current hot research topics is investigating the role of AhR activation by environmental pollutants on glucose homeostasis and insulin secretion, and hence the pathogenesis of diabetes mellitus. To date, epidemiological studies have suggested that persistent exposure to environmental contaminants such as dioxins, with subsequent AhR activation increases the risk of specific comorbidities such as obesity and diabetes. The importance of AhR signaling in various molecular pathways highlights that the role of this receptor is far beyond just xenobiotic metabolism. The present review aims at providing significant insight into the physiological and pathological role of AhR and its regulated enzymes, such as cytochrome P450 1A1 (CYP1A1) and CYP1B1 in both types of diabetes. It also provides a comprehensive summary of the current findings of recent research studies investigating the role of the AhR/CYP1A1 pathway in insulin secretion and glucose hemostasis in the pancreas, liver, and adipose tissues. This review further highlights the molecular mechanisms involved, such as gluconeogenesis, hypoxia-inducible factor (HIF), oxidative stress, and inflammation.